Novo Nordisk stock surges 4%: can NHS boost offset pricing pressure?

Novo Nordisk stock surged on Wednesday after a major policy win, which is seen as a turning point for the drugmaker. England's cost-effectiveness watchdog has backed broader use of Wegovy to cut the risk of heart attacks and strokes in overweight or obese adults.